The main research interests are the development and clinical translation of novel diagnostic and therapeutic radiotracers in the field of oncology including neuroendocrine tumors.
Selected Publications
Beck, Julia, Siebenhüner, Alexander, , Christ, Emanuel, & Refardt, Julie. (2024). Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms. Endocrine-Related Cancer, 31(3). https://doi.org/10.1530/ERC-23-0235
Beck, Julia, Siebenhüner, Alexander, , Christ, Emanuel, & Refardt, Julie. (2024). Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms. Endocrine-Related Cancer, 31(3). https://doi.org/10.1530/ERC-23-0235
Eigler, Christopher, McDougall, Lisa, Bauman, Andreas, Bernhardt, Peter, Hentschel, Michael, Blackham, Kristine A., Nicolas, Guillaume, Fani, Melpomeni, , & Cordier, Dominik. (2024). Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study. Journal of Nuclear Medicine, 65(4), 573–579. https://doi.org/10.2967/jnumed.123.266817
Eigler, Christopher, McDougall, Lisa, Bauman, Andreas, Bernhardt, Peter, Hentschel, Michael, Blackham, Kristine A., Nicolas, Guillaume, Fani, Melpomeni, , & Cordier, Dominik. (2024). Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study. Journal of Nuclear Medicine, 65(4), 573–579. https://doi.org/10.2967/jnumed.123.266817
Fricke, Julia, Westerbergh, Frida, McDougall, Lisa, Favaretto, Chiara, Christ, Emanuel, Nicolas, Guillaume P., Geistlich, Susanne, Borgna, Francesca, Fani, Melpomeni, Bernhardt, Peter, van der Meulen, Nicholas P., Müller, Cristina, Schibli, Roger, & . (2024). First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([ 161 Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European Journal of Nuclear Medicine and Molecular Imaging, 51, 2517–2519. https://doi.org/10.1007/s00259-024-06641-w
Fricke, Julia, Westerbergh, Frida, McDougall, Lisa, Favaretto, Chiara, Christ, Emanuel, Nicolas, Guillaume P., Geistlich, Susanne, Borgna, Francesca, Fani, Melpomeni, Bernhardt, Peter, van der Meulen, Nicholas P., Müller, Cristina, Schibli, Roger, & . (2024). First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([ 161 Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European Journal of Nuclear Medicine and Molecular Imaging, 51, 2517–2519. https://doi.org/10.1007/s00259-024-06641-w
Friebe, Liene, Freitag, Martin T., Braun, Martin, Nicolas, Guillaume, Bauman, Andreas, Bushnell, David, Christ, Emanuel, & . (2024). Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis. Journal of Nuclear Medicine, 65, 228–235. https://doi.org/10.2967/jnumed.123.265894
Friebe, Liene, Freitag, Martin T., Braun, Martin, Nicolas, Guillaume, Bauman, Andreas, Bushnell, David, Christ, Emanuel, & . (2024). Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis. Journal of Nuclear Medicine, 65, 228–235. https://doi.org/10.2967/jnumed.123.265894
, Grønbæk, Henning, Navalkissoor, Shaunak, Haug, Alexander, Nicolas, Guillaume P., Pais, Ben, Ansquer, Catherine, Beauregard, Jean-Mathieu, McEwan, Alexander, Lassmann, Michael, Pennestri, Daniele, Volteau, Magali, Lenzo, Nat P., & Hicks, Rodney J. (2023). A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging, 51(1), 183–195. https://doi.org/10.1007/s00259-023-06383-1
, Grønbæk, Henning, Navalkissoor, Shaunak, Haug, Alexander, Nicolas, Guillaume P., Pais, Ben, Ansquer, Catherine, Beauregard, Jean-Mathieu, McEwan, Alexander, Lassmann, Michael, Pennestri, Daniele, Volteau, Magali, Lenzo, Nat P., & Hicks, Rodney J. (2023). A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging, 51(1), 183–195. https://doi.org/10.1007/s00259-023-06383-1